Net income changed across a low base
Net income changed +1463.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$10.5M→$164.2M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ROKU financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure increased 236.0%
Capital expenditure changed +236.0% from the comparable as-filed period.
$1.1M→$3.8M3 prior comparisons
Free-cash-flow margin moved 1096 bp higher
Free-cash-flow margin changed +1096 basis points from the comparable as-filed period.
9.78%→20.73%2 prior comparisons
Working capital / assets moved 348 bp higher
Working capital / assets changed +348 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
47.88%→51.35%4 prior comparisons
SBC / revenue moved 206 bp lower
SBC / revenue changed -206 basis points from the comparable as-filed period.
7.62%→5.56%2 prior comparisons
R&D / revenue moved 276 bp lower
R&D / revenue changed -276 basis points from the comparable as-filed period.
16.02%→13.26%2 prior comparisons
Cash & equivalents decreased 11.2%
Cash & equivalents changed -11.2% from the comparable as-filed period.
$2.3B→$2.0B3 prior comparisons
Operating cash-flow margin moved 1114 bp higher
Operating cash-flow margin changed +1114 basis points from the comparable as-filed period.
9.88%→21.01%2 prior comparisons
Operating cash flow / net income decreased 83.4%
Operating cash flow / net income changed -83.4% from the comparable as-filed period.
10.45→1.730 prior comparisons
Inventory / revenue moved 155 bp lower
Inventory / revenue changed -155 basis points from the comparable as-filed period.
10.14%→8.59%2 prior comparisons
Capex / revenue moved 18 bp higher
Capex / revenue changed +18 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.10%→0.28%2 prior comparisons
Cost of revenue increased 11.0%
Cost of revenue changed +11.0% from the comparable as-filed period.
$613.4M→$681.0M2 prior comparisons
Receivables / revenue moved 76 bp higher
Receivables / revenue changed +76 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
56.57%→57.33%2 prior comparisons
Stock-based compensation decreased 11.0%
Stock-based compensation changed -11.0% from the comparable as-filed period.
$84.6M→$75.3M2 prior comparisons
Inventory increased 3.3%
Inventory changed +3.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$112.7M→$116.4M4 prior comparisons
Research & development increased 0.9%
Research & development changed +0.9% from the comparable as-filed period.
$178.0M→$179.7M2 prior comparisons
Current ratio increased 0.6%
Current ratio changed +0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
2.85→2.874 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.